Jun 13, 2022· Comment from ACT | The App Association· FDA-2021-D-0789-0070
Connected Health Initiative Comments on the Food and Drug Administration's Draft Guidance for Industry on "Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials" [Docket No. FDA-2021-D-0789]